KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

KabaFusion partners with CareCloud to develop a fully integrated application, powered by artificial intelligence, designed for the home infusion workflow

Somerset, NJ and Lexington, MA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- KabaFusion, one of the nation's largest providers of home infusion therapy, and CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in healthcare technology, today announced a partnership to build LailaCare, a platform powered by artificial intelligence and designed to support and modernize KabaFusion's operations as a home infusion and specialty pharmacy provider. CareCloud will design and develop the platform, which will be owned by KabaFusion.